Table 2.

Multivariate analysis of factors influencing survival in R/R-AML patients treated with venetoclax.

Variable	Median (Days)	P-Univariate	P-Multivariate	HR (95% CI)
Total, n = 47	78
Age
<65 y, n = 17	34	0.919	0.326	1.48 (0.68–3.22)
≥65 y, n = 34	34
Sex
Female, n = 18	131	0.217	0.010	3.37 (1.45–7.82)
Male, n = 33	78
ECOG performance status
0, n = 10	NR	0.001	0.005	14.96 (1.91–117.21)
≥1, n = 40	75
ORR (CR + CRi + PR)
Yes,11	215	0.004	0.002	6.13 (0.68–3.22)
No, 37	69

Abbreviations: CR, complete remission; CRi, CR with incomplete blood count recovery; ECOG, Eastern Cooperative Oncology Group scale; PR, partial response; R/R-AML, relapsed/refractory acute myeloid leukemia.